MyAverix Finance MyAverix Finance

SA

Arrowhead Pharmaceuticals, Inc. (A2RR34)

Arrowhead Pharmaceuticals, Inc. (A2RR34) is listed on SA. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for A2RR34

P/E ratio
18.00

Arrowhead Pharmaceuticals, Inc. (A2RR34) — FAQ

What is A2RR34's P/E ratio?

The price-to-earnings (P/E) ratio for Arrowhead Pharmaceuticals, Inc. (A2RR34) is 18.00 (data as of 2026-05-23).

Does Arrowhead Pharmaceuticals, Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Arrowhead Pharmaceuticals, Inc. (A2RR34). Check the MyAverix Finance app for the latest dividend data.

What exchange is A2RR34 listed on?

A2RR34 is listed on SA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play